MobiHealthNews

Adherium receives OTC clearance for AstraZeneca's Symbicort inhaler

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...
MobiHealthNews

FDA clears Adherium's third inhaler sensor, for AstraZeneca's Symbicort inhaler

Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device ...
MarketWatch

AstraZeneca: Symbicort inhaler cuts asthma attacks 22%

SAN FRANCISCO (MarketWatch) -- AstraZeneca PLC said Monday that results from a one-year study show that patients taking its Symbicort single-inhaler therapy had fewer asthma attacks and required less ...
FiercePharma

Viatris prevails in another patent feud over AZ's blockbuster asthma med Symbicort

In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...
Business Wire

Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform

MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...
Wall Street Journal

Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?

AstraZeneca’s move on Monday to cap at $35 the out-of-pocket costs that patients pay for the company’s Symbicort inhaler speaks to the political and regulatory pressure coming to bear on manufacturers ...
Fox 5 San Diego

AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (The Hill) — Drugmaker AstraZeneca will cap ...
Yahoo

Some drugmakers to cap cost of asthma inhalers at $35 a month

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...
Nasdaq

FDA Approves First Generic Of Symbicort To Treat Asthma, COPD

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
Penn Live

FDA gives approval for first generic of Symbicort inhaler for treatment of asthma, COPD

The U.S. Food and Drug Administration said yesterday that it has given approval for the first generic of the Symbicort inhaler to treat asthma and COPD. Symbicort is a combination of budesonide and ...
Healio

FDA approves first generic of Symbicort for asthma, COPD

Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of the first generic of Symbicort — budesonide and formoterol fumarate dihydrate — ...